Profound Medical (PROF) Invested Capital (2018 - 2026)
Profound Medical has reported Invested Capital over the past 8 years, most recently at $70.9 million for Q4 2025.
- For Q4 2025, Invested Capital rose 8.99% year-over-year to $70.9 million; the TTM value through Dec 2025 reached $70.9 million, up 8.99%, while the annual FY2025 figure was $70.9 million, 8.99% up from the prior year.
- Invested Capital for Q4 2025 was $70.9 million at Profound Medical, up from $36.6 million in the prior quarter.
- Over five years, Invested Capital peaked at $74.5 billion in Q1 2022 and troughed at $30.7 million in Q3 2024.
- A 5-year average of $6.5 billion and a median of $59.8 million in 2022 define the central range for Invested Capital.
- Biggest five-year swings in Invested Capital: skyrocketed 107887.15% in 2021 and later tumbled 99.91% in 2024.
- Year by year, Invested Capital stood at $80.6 million in 2021, then fell by 25.88% to $59.8 million in 2022, then crashed by 35.88% to $38.3 million in 2023, then surged by 69.81% to $65.1 million in 2024, then grew by 8.99% to $70.9 million in 2025.
- Business Quant data shows Invested Capital for PROF at $70.9 million in Q4 2025, $36.6 million in Q3 2025, and $43.7 million in Q2 2025.